Comparison of safety and immunogenicity of purified chick embryo cell vaccine using Zagreb and Essen regimens in patients with category II exposure in China-Reference-Cited by-同舟云学术

Comparison of safety and immunogenicity of purified chick embryo cell vaccine using Zagreb and Essen regimens in patients with category II exposure in China

Published:2014-03-14 Issue:6 Volume:10 Page:1645-1649
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Hu Quan,Liu Man-Qing,Zhu Zheng-Gang,Zhu Ze-Rong,Lu Sha

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/hv.28420

Reference11 articles.

1. Inadequate Antibody Response to Rabies Vaccine in Immunocompromised Patient

2. Rabies virus vaccines: Is there a need for a pan-lyssavirus vaccine?

3. Epidemiological investigations of human rabies in China

4. The immunogenicity and safety of vaccination with purified Vero cell rabies vaccine (PVRV) in China under a 2-1-1 regimen

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Randomized, blind, controlled phase III clinical trial: Assessing the immunogenicity and safety of freeze-dried human rabies vaccine (vero cell) with a 4-dose regimen (2-1-1) in a 10–60 year-old demographic;Vaccine;2024-10

2. A Randomized, Double-Blind, Controlled Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of a Lyophilized Human Rabies Vaccine (Vero Cells) in Healthy Participants Aged 10–60 Years Following Essen and Zagreb Vaccination Procedures;Vaccines;2023-08-01

3. Safety of purified Vero cell rabies vaccine manufactured in Pakistan: a comparative analysis of intradermal and intramuscular routes;Current Medical Research and Opinion;2023-04-17

4. Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10–50 years old: Randomized, blinded, parallel controlled phase III clinical study;Human Vaccines & Immunotherapeutics;2023-01-02

5. Safety and immunogenicity of human rabies vaccine for the Chinese population after PEP: A systematic review and meta-analysis;Vaccine;2022-07